Cargando…
Counting‐based cell‐free DNA screening test fails to identify triploidy—A case report
Although noninvasive prenatal testing (NIPT) is a good test with high sensitivity and specificity for trisomy 21, 18, and 13, it remains a screening test and cannot be used for diagnostic purposes. It is important to consider the outcomes of this test and interpret the results and offer consultation...
Autores principales: | Park, Ji E., Park, Ji K., Kang, Min Y., Cho, In A., Baek, Jong C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332828/ https://www.ncbi.nlm.nih.gov/pubmed/30656016 http://dx.doi.org/10.1002/ccr3.1812 |
Ejemplares similares
-
Triploidy and Routine Combined First Trimester Pregnancy Screening
por: Eftekhariyazdi, Mitra, et al.
Publicado: (2019) -
Triploidy in a fetus following amniocentesis referred for maternal serum screening test at second trimester
por: Bagherizadeh, E., et al.
Publicado: (2010) -
Digynic triploidy: utility and challenges of noninvasive prenatal testing
por: Fleischer, Julie, et al.
Publicado: (2015) -
Fetal fraction‐based risk algorithm for non‐invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell‐free fetal DNA
por: McKanna, T., et al.
Publicado: (2018) -
Triploidy—Observations in 154 Diandric Cases
por: Scholz, Nanna Brink, et al.
Publicado: (2015)